Latest news for Waldencast (NASDAQ:WALDW) Stock

Waldencast PLC is a beauty and wellness operating platform by developing, acquiring, accelerating, and scaling the next generation of conscious, purpose-driven brands. It is organized into two reportable segments namely Obagi Skincare and Milk Makeup.

Waldencast PLC

WIIM

Kiniksa Pharmashares are trading higher after the company announced expectations for preliminary Q4 revenue to be at the high end of the guidance range.

News

Analyst Ratings

Trading Ideas

REGN

Live On CNBC, Rob Sechan Announces Sold Regeneron

Keefe, Bruyette &amp; Woods analyst Aidan Hall maintains Lazard (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LAZ#NYSE">LAZ</a>) with a Market Perform and lowers the price target from $57 to $52.

Price Target

Keefe, Bruyette & Woods Maintains Market Perform on Lazard, Lowers Price Target to $52

SIBN

SI-BONE shares are trading higher after the company reported preliminary Q4 revenue results.

Argus Research analyst Kristina Ruggeri downgrades Ethan Allen Interiors (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ETD#NYSE">ETD</a>) from Buy to Hold.

Downgrades

Argus Research Downgrades Ethan Allen Interiors to Hold

Keefe, Bruyette &amp; Woods analyst Kyle Voigt maintains KKR (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KKR#NYSE">KKR</a>) with a Outperform and lowers the price target from $170 to $168.

Keefe, Bruyette & Woods Maintains Outperform on KKR, Lowers Price Target to $168

Essex Property Trust shares are trading higher after BMO capital upgraded the stock from Market Perform to Outperform.

Citigroup analyst Andrew Kaplowitz maintains Eaton Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ETN#NYSE">ETN</a>) with a Buy and lowers the price target from $440 to $410.

Citigroup Maintains Buy on Eaton Corp, Lowers Price Target to $410

ESTA

Establishment Labs shares are trading lower after the company announced a CEO transition.

America's troubled commercial real estate industry avoided a sector-wide meltdown in 2024, but that doesn't mean it was a good year. A recent study by real estate data firm ATTOM showed an alarming increase in commercial real estate foreclosures in the final quarter of 2024. Their data shows foreclosure activity was up by 48% nationwide in comparison to the same time one year prior.
September 2024 saw a whopping 695 commercial real estate foreclosures. California, which also has some of the highest property values in the nation, won the dubious distinction of leading the nation in foreclosures. ATTOM's data shows 264 of the 695 September foreclosures were in the Golden State. That was a 12% increase over the August total, but more alarmingly, a 238% increase over the previous year.
Don't Miss:
<ul>
<li>If there was a new fund backed by Jeff Bezos offering a <a href="https://www.benzinga.com/go/arrived-private-credit-yf">7-9% target yield with monthly dividends would you invest in it</a>?</li>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-y2">Last Chance to get 4,000 of its pre-IPO shares for just $0.26/share!</a></li>
</ul>
<a href="https://www.benzinga.com/real-estate/24/12/42617007/ignore-new-york-at-your-peril-nyc-office-market-hits-overdrive-breathing-life-into-the-citys-business-and-real-estate">New York</a> was next on the list with 95 foreclosures, which was a 58% surge from the previous months and 48% more than September 2023. Both states have extremely active real estate markets in major population centers, meaning the foreclosures likely represented billions in losses for the affected banks. Although these numbers caused alarm, they did not come as a surprise.
Going into 2024, many economists and real estate observers were worrying about how much commercial real estate debt was on the books as unrealized losses for America's financial institutions. "<a href="https://www.foxbusiness.com/video/6345425740112">The Bear Trap Report</a>" founder Larry McDonald told Fox's Maria Bartiromo that $700 billion in commercial loans were set to mature in 2024.
McDonald described it as "a slow-moving train wreck," and darker days may be on the horizon. When McDonald made his dire prediction, he expressed hope that the debt levels would force the Federal Reserve to lower interest rates significantly by year's end. The rate cuts came, but they were not deep enough to spur<a href="https://www.benzinga.com/real-estate/25/01/42845317/homes-are-lingering-redfin-reports-u-s-housing-supply-up-12-as-2024-ends-with-954703-active-listings"> America's housing market</a> back to life or stave off the wave of foreclosures reported by ATTOM.
See Also: Commercial real estate has historically outperformed the stock market, and<a href="https://equitymultiple.com/benzinga?invite=benzinga&amp;utm_campaign=product-promotion-earn&amp;utm_source=yahooFinance&amp;utm_medium=affiliate&amp;utm_content=stockmarket-yahoo"> this platform allows individuals to invest in commercial real estate with as little as $5,000 offering a 12% target yield with a bonus 1% return boost today!</a>
That could be a problem because many commercial developers and borrowers spent most of 2024 living by an unspoken policy that some referred to as "extend and pretend." Under this policy, commercial lenders extended terms for borrowers in the hopes that people would return to work in large enough numbers to cause commercial property values to rebound. By and large, that hasn't happened and there is even more debt on the horizon.
Speaking to Business Insider, Capital Economics Chief Property Economist Kiran Raichura said another $2.2 trillion in commercial debt will mature by 2027. It's almost impossible to imagine that lenders and developers can push all that debt down the road and have the Federal Reserve rescue them by slashing interest rates into the three or four percent range. That means the recent foreclosure spike might eventually be seen as just a drop in the bucket.
Trending: This Jeff Bezos-backed startup will allow you to <a href="https://arrivedhomes.go2cloud.org/aff_c?offer_id=15&amp;aff_id=1006&amp;aff_sub=yahoo&amp;aff_sub2=byerscta100">become a landlord in just 10 minutes, with minimum investments as low as $100 for properties like the Byer House from Stranger Things.</a>
Raichura said, &#8220;We expect evidence of distress to ramp up this year as loan extensions end. Many borrowers will be forced to inject new capital, return assets to lenders or sell into a soft market. Those assets returned to lenders will ultimately end up on the market, helping bring greater pricing clarity and more substantial valuation markdowns.&#8221;
ATTOM has been tracking monthly commercial real estate foreclosures since 2014. Their data shows a 10-year-high of 889 foreclosures in September 2014. The $2.2 trillion on the books for 2027 is roughly triple the commercial debt that matured in 2024. Commercial developers and lenders could find themselves in dire straits if that leads to a corresponding 300% increase in foreclosures. Consider this when making long-term real estate investments in the commercial sector.
Wondering if your investments can get you to a $5,000,000 nest egg? Speak to a financial advisor today.<a href="https://smartasset.com/retirement/find-a-financial-planner?utm_source=benzinga&amp;utm_campaign=ben&amp;utm_content=y2_5MilNestEgg"> SmartAsset&#8217;s free tool matches you up with up to three vetted financial advisors who serve your area, and you can interview your advisor matches at no cost</a> to decide which one is right for you.&nbsp;
<h2 class="wp-block-heading">Interest Rates Are Falling, But These Yields Aren't Going Anywhere</h2>
Lower interest rates mean some investments won't yield what they did in months past, but you don't have to lose those gains. Certain private market real estate investments are giving retail investors the opportunity to capitalize on these high-yield opportunities.
<a href="https://www.benzinga.com/go/arrived-private-credit-yf">Arrived Home's Private Credit Fund&#8217;s has historically paid an annualized dividend yield of 8.1%&#x2A;</a>, which provides access to a pool of short-term loans backed by residential real estate. The best part? Unlike other private credit funds, <a href="https://www.benzinga.com/go/arrived-private-credit-yf">this one has a minimum investment of only $100.&nbsp;</a>
Looking for fractional real estate investment opportunities? The <a href="https://www.benzinga.com/alternative-investments/real-estate">Benzinga Real Estate Screener</a> features the latest offerings.

Real Estate

Commercial Real Estate Foreclosures Spiked By Nearly 50% In Late 2024 – Is The Long-Dreaded Market Correction Finally Here?

In the current market session, Crown Castle Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCI#NYSE">CCI</a>) price is at $84.64, after a 0.37% spike. However, over the past month, the stock decreased by 10.79%, and in the past year, by 23.63%. Shareholders might be interested in knowing whether the stock is undervalued, even if the company is performing up to par in the current session. 

<img src="https://www.benzinga.com/files/images/story/2025/1736789407_0.png" alt="Past Year Chart" />

<h3>Crown Castle P/E Compared to Competitors</h3>
The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E could indicate that shareholders do not expect the stock to perform better in the future or it could mean that the company is undervalued. 
Compared to the aggregate P/E ratio of the 52.19 in the Specialized REITs industry, Crown Castle Inc. has a lower P/E ratio of 29.9. Shareholders might be inclined to think that the stock might perform worse than it's industry peers. It's also possible that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1736789407_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

Intraday Update

Markets

P/E Ratio Insights for Crown Castle

SAGE

Sage Therapeutics shares are trading higher after the company confirmed the receipt of an unsolicited, nonbinding proposal from Biogen to acquire all outstanding shares not already owned by Biogen for $7.22 per share.

Keefe, Bruyette &amp; Woods analyst Kyle Voigt maintains Intercontinental Exchange (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ICE#NYSE">ICE</a>) with a Outperform and lowers the price target from $183 to $178.

Keefe, Bruyette & Woods Maintains Outperform on Intercontinental Exchange, Lowers Price Target to $178

HC Wainwright &amp; Co. analyst Amit Dayal maintains Calumet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLMT#NASDAQ">CLMT</a>) with a Buy and raises the price target from $25 to $33.

CLMT

HC Wainwright & Co. Maintains Buy on Calumet, Raises Price Target to $33

Citigroup analyst Andrew Kaplowitz maintains Dover (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOV#NYSE">DOV</a>) with a Buy and lowers the price target from $236 to $222.

Citigroup Maintains Buy on Dover, Lowers Price Target to $222

Keefe, Bruyette &amp; Woods analyst Kyle Voigt maintains Interactive Brokers Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBKR#NASDAQ">IBKR</a>) with a Market Perform and raises the price target from $190 to $195.

IBKR

Keefe, Bruyette & Woods Maintains Market Perform on Interactive Brokers Gr, Raises Price Target to $195

Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>) is down 8% on the day to $3,020, leading analysts to discuss whether there is any bullish hope left for the <a href="https://www.benzinga.com/money/ethereum-eth-price-predictions">second-largest cryptocurrency</a>.
What Happened: Prominent whale trader Adam referred to Ethereum as a "cursed coin." 
Despite open interest rising by 110% since August, Ethereum never came closer than 20% below its all-time high. 
The trader <a href="https://x.com/abetrade/status/1878542644738994257">suggests</a> two strategies for entering a long position:
<ol start="1">
<li>Buy after a liquidation event below $3,000.</li>
<li>Place bids near $2,700, a key support level, if no liquidation event occurs.</li>
</ol>
Chart analyst Ali Martinez identified critical resistance for Ethereum between $3,360-$3,450 and key support between $3,066-$3,160.
 He also <a href="https://x.com/ali_charts/status/1878737753460166971">noted</a> that three whale wallets currently control around 43% of Ethereum&#8217;s total supply.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">The most critical resistance level for <a href="https://twitter.com/hashtag/Ethereum?src=hash&amp;ref_src=twsrc%5Etfw">#Ethereum</a> <a href="https://twitter.com/search?q=%24ETH&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$ETH</a> lies between $3,360 and $3,450, while key support is found between $3,066 and $3,160. <a href="https://t.co/gE0vEW35vb">pic.twitter.com/gE0vEW35vb</a>
&mdash; Ali (@ali_charts) <a href="https://twitter.com/ali_charts/status/1878593160383025288?ref_src=twsrc%5Etfw">January 13, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/01/42899397/ethereum-price-drops-5-in-7-days-truly-an-excellent-buy-the-dip-opportunity">Ethereum Price Drops 5% In 7 Days: Truly An &#8216;Excellent Buy-The-Dip Opportunity&#8217;?</a>
Why It Matters: Benjamin Cowen, CEO of IntoTheCryptoverse, <a href="https://x.com/intocryptoverse/status/1878659316128887050">highlighted</a> that Ethereum's supply is set to return to pre-Merge levels within weeks, growing by 45,000 ETH per month and currently just 32,000 ETH below the pre-merge supply. 
Despite initial demand improvements after rate cuts, 10 months of inflationary supply growth have kept prices under pressure. &nbsp;
Lookonchain data revealed that whales <a href="https://x.com/lookonchain/status/1878827859013521412">withdrew</a> 10,000 ETH (worth $30.76 million) from Binance. 
IntoTheBlock data shows large transactions volume increased by 70.2%, while transactions greater than $100,000 dipped marginally from 3,406 to 3,281. Exchanges netflows spiked 791.5%.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42724952/2025-outlook-bitcoin-to-150000-ethereum-to-5500-dogecoin-hits-1-galaxy-research-predicts">2025 Outlook: Bitcoin To $150,000, Ethereum To $5,500, Dogecoin Hits $1, Galaxy Research Predicts</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$ETH

'Cursed Coin' Ethereum Down 8%: What Is Going On?

– Preliminary total net product revenue of $638.2 million for the fourth quarter and $1.79 billion for full-year 2024, exceeding full-year guidance by over $100 million
– Preliminary ELEVIDYS net product revenue totaled $384.2 million for the fourth quarter, exceeding guidance by over $60 million, and $820.8 million for full-year 2024
– Preliminary RNA-based PMO net product revenue for the fourth quarter and full-year of 2024 totaled $254.0 million and $967.2 million, respectively
– Preliminary year-end 2024 cash, cash equivalents, restricted cash and investments balance of approximately $1.5 billion
– Reiterates 2025 full-year total net product revenue guidance of $2.9 to $3.1 billion
Sarepta Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRPT#NASDAQ">SRPT</a>), the leader in precision genetic medicine for rare diseases, today reported preliminary&#x2A; fourth quarter and full-year 2024 net product revenue and cash on hand as of December 31, 2024, as part of its presentation today at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, Calif.

Earnings

Guidance

SRPT

Sarepta Announces Q4 2024 Revenue Of $638.2M, Exceeding Guidance; ELEVIDYS Revenue At $384.2M; RNA PMO Revenue At $254M; FY24 Revenue Totals $1.79B; $1.5B In Cash And Investments At Year-End 2024; Reiterates 2025 Revenue Guidance Of $2.9B-$3.1B

Wix.com shares are trading higher after Morgan Stanley upgraded the stock from Equal-Weight to Overweight and raised its price target from $248 to $276.

Citigroup analyst Andrew Kaplowitz maintains CSW Industrials (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSWI#NASDAQ">CSWI</a>) with a Neutral and lowers the price target from $466 to $404.

CSWI

Citigroup Maintains Neutral on CSW Industrials, Lowers Price Target to $404

Waldencast plc (WALD) Q1 2024 Earnings Call Transcript

Waldencast: Price Can Fall Further For Now, But Medium Term Potential Exists

Waldencast plc (WALD) Q2 2024 Earnings Call Transcript

Waldencast plc 2024 Q2 - Results - Earnings Call Presentation

Waldencast plc. (WALD) Q3 2024 Earnings Call Transcript

WALD

WALDW

Press Releases

Waldencast plc (WALD, WALDW) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings

ROSEN, A LEADING LAW FIRM, Encourages Waldencast plc Investors to Inquire About Securities Class Action Investigation – WALD, WALDW

Johnson Fistel, LLP is Investigating Waldencast for Violation of Securities Laws; WALD, WALDW

BellRing Brands

Coty

Big Tree Cloud Holdings Limited - Ordinary Shares

Big Tree Cloud Holdings

Estee Lauder Companies, Inc. (The) Common Stock

Estee Lauder Cos

e.l.f. Beauty

Edgewell Personal Care Company Common Stock

Edgewell Personal Care

FitLife Brands

Herbalife

Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

Haleon

Honest Co

Interparfums

Kenvue

Lifevantage

Medifast

Nature's Sunshine Products, Inc. - Common Stock

Natures Sunshine Products

Natural Health Trends Corp. - Commn Stock

Natural Health Trends

Nu Skin Enterprises

Olaplex Hldgs

Paranovus Entertainment Technology Ltd. - Class A Ordinary Shares

Paranovus Enter

The Beauty Health Company - Class A Common Stock

Beauty Health

United-Guardian

Unilever

Usana Health Sciences

Veru

Waldencast

Yatsen Holding Limited American Depositary Shares, each representing twenty (20) Class A Ordinary Shares

Comments

Waldencast

News

Latest news for Waldencast (NASDAQ:WALDW) Stock

People Also Watch

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga